Objectives: To quantify variation in use and complications from peripherally inserted central catheters placed in the ICU versus peripherally inserted central catheters placed on the general ward. Design: Retrospective cohort study. Setting: Fifty-two hospital Michigan quality collaborative. Patients: Twenty-seven-thousand two-hundred eighty-nine patients with peripherally inserted central catheters placed during hospitalization. Measurements and Main Results: Descriptive statistics were used to summarize patient, provider, and device characteristics. Bivariate tests were used to assess differences between peripherally inserted central catheters placed in the ICU versus peripherally inserted central catheters placed on the ward. Multilevel mixedeffects generalized linear models adjusting for patient and device factors with a logit link clustered by hospital were used to examine the association between peripherally inserted central catheter complications and location of peripherally inserted central catheter placement. Variation in ICU peripherally inserted central catheter use, rates of complications, and appropriateness of use across hospitals was also examined. Eight-thousand two-hundred eighty patients (30.3%) received peripherally inserted central catheters in the ICU versus 19,009 (69.7%) on the general ward.
C entral venous access is one of the most common components in the care of critically ill patients (1) (2) (3) (4) . Each year, over 7 million central venous catheters (CVCs) are placed in the United States alone (3, 5) . Furthermore, between 50% and 80% of critically ill patients require central venous access at some point during their stay in the ICU (1, 2) . Although invasive catheters are often placed for life-saving reasons, they are associated with substantial morbidity and mortality (6, 7) . Mechanical complications occur at a rate of 5-19% and may necessitate device removal (3) . Similarly, central line-associated bloodstream infection (CLABSI) continues to occur in thousands of critically ill patients every year (8) , and catheter-associated venous thromboembolism (VTE) impacts 14% of critically ill patients (9) . Therefore, the risks and benefits of central venous access must be weighed carefully and often in the ICU.
Over the past decade, central venous access patterns in the ICU have changed with increasing use of peripherally inserted central catheters (PICCs) (10) . Multiple reasons underlie growing PICC use in the critically ill patient: ease of insertion (11) , perceived safety compared with traditional CVCs (12) , ability to facilitate transitions in care (13) , and variation in intensivist staffing leading to challenges with inserting traditional CVCs (14) . However, use of PICCs in the ICU may also lead to increased risk of complications (9, 15, 16) . A systematic review comparing PICCs to CVCs showed that PICCs are 2.5 times more likely to experience VTE compared with CVCs, and critically ill patients were at highest risk for PICC-related VTE (9) . ICU status is also associated with a significantly increased risk for PICC-related CLABSI (17) .
Recently, appropriateness criteria for PICC use in ICU and ward settings were introduced (18) . However, few largescale studies describe the epidemiology of PICC use in the ICU. Furthermore, it is not known whether practice patterns regarding PICC use in the ICU vary across hospitals, nor to what extent recommendations from these criteria are being followed. Better understanding practice variation, particularly device-specific utilization patterns, is the first step to implementing vascular access decision aides. Therefore, using data from a multihospital quality collaborative in Michigan, we compared the use of PICCs placed in the ICU versus PICCs placed on the general ward. We assessed differences in patient, PICC, provider characteristics, and outcomes. We then characterized the site-specific variation regarding PICC use and vascular outcomes in critically ill patients across hospitals.
METHODS

Study Setting and Population
This study used data from the Michigan Hospital Medicine Safety (HMS) Consortium, a 52-hospital, state-wide quality collaborative supported by Blue Cross Blue Shield of Michigan and Blue Care Network. The setting and design of HMS have been previously described (19) (20) (21) . Briefly, HMS hospitals have been collecting data on PICC use and outcomes in a sample of hospitalized patients since 2014. Although data collection began across all hospitals in 2014, some pilot hospitals were collecting data since November 2013. In addition, some hospitals place less than 200 PICCs per year and are defined as "low-volume" sites; as rates of use and outcomes might vary at these sites, they were also included. The collaborative collects data on adult medical patients admitted to a general ward or ICU within a participating hospital who had a PICC placed for any reason during the course of clinical care.
At each hospital, a dedicated and trained medical record abstractor uses a standardized template to collect data directly from the patient medical record. Patients with PICCs are sampled every 14 days, and data from the first 17 cases that meet eligibility requirements are abstracted. To ensure adequate representation of critically ill patients, seven of the 17 records include patients with a PICC placed in the ICU. Patients are excluded if they are under 18 years old, pregnant, admitted to a nonmedical service (i.e., surgery), or admitted under observation status. Following PICC placement, all patients are followed until PICC removal, death, or 70-days, whichever occurs first. For this analysis, complete data on PICCs placed from November 2013 to May 2017 were included.
Definitions
Patient, device, and provider characteristics known to be associated with VTE, CLABSI, or catheter occlusion were identified using two validated conceptual models (22, 23) . Detailed patient demographics, including VTE and central line-associated bloodstream infection within 6 months of PICC placement, were abstracted from the medical record. The presence of additional CVCs was identified and recorded.
Information regarding device and insertion characteristics were obtained from vascular nursing or interventional radiology notes. Indication for index PICC placement was determined through evaluation of the physician order for PICC placement, interventional radiology insertion note, or vascular access note. PICCs were recorded as placed in the ICU if placement was documented in the ICU or placement occurred on or after the date of ICU admission but prior to the date of ICU discharge. PICCs placed in the emergency department or outpatient setting were excluded from the analysis. Additionally, data on the delivery of certain infusates through the PICC, including specific antibiotic agents and packed RBCs, were collected.
PICC complications were defined as major versus minor events. Major events included VTE (defined as symptomatic, radiographically confirmed [i.e., positive ultrasound or CT], upper extremity deep vein thrombosis, or pulmonary embolism). CLABSI was defined according to the Centers for Disease Control and Prevention National Healthcare Safety Network criteria (13) . Cases of suspected CLABSI without supportive microbiologic findings (e.g., PICC removed without confirmatory blood cultures) were also identified and included. Minor events included catheter occlusion, which was captured when documented in the medical record or when tissue plasminogen activator was administered for problems with aspiration or infusion.
Outcomes
The primary outcome of interest was the difference in composite rate of CLABSI, VTE, and catheter occlusion during the study period by location of PICC placement (ICU vs ward). Secondary outcomes included: 1) PICC utilization characteristics and 2) differences in complications by location of PICC placement. Additionally, site-level variation in PICC use and the composite rate of CLABSI, VTE, and occlusion for ICUplaced PICCs were assessed.
Statistical Analysis
Descriptive statistics were used to tabulate patient and PICC characteristics. t, chi-square, and Wilcoxon ranksum tests assessed differences between PICCs placed in the ICU versus PICCs placed on the ward, by patient and PICC characteristics. Multilevel mixed-effects generalized linear models with a logit link, binomial distribution and clustered by hospital evaluated for an association between adverse events and location of PICC placement. These were adjusted for patient, provider, and device characteristics in accordance with validated models (22, 23) .
For PICCs placed in the ICU, differences in complication rates by number of lumens, gauge, operator inserting the device, and presence of a CVC were assessed using chi-square and Fisher exact tests. Variation in PICC indications, number of lumens, median dwell time, and adverse outcomes across hospitals were evaluated using chi-square and Kruskal-Wallis tests, respectively. Results were expressed as percentages, means, medians, and odds ratios with corresponding 95% CIs. Statistical significance was assessed at p value of less than 0.05. Stata v14 (StataCorp, College Station, TX) was used for all analyses.
Ethical and Regulatory Oversight
The University of Michigan Medical School's Institutional Review Board reviewed this study and deemed it "not regulated" status.
RESULTS
During the study period, a total of 27,289 patients with PICCs were included in the analysis. A total of 8,280 patients (30.3%) received PICCs in the ICU while 19,009 (69.7%) received PICCs on the general ward. Of the 52 hospitals included, 85.4% (n = 41) were teaching institutions, 83.3% (n = 40) were nonprofit, and the average bed size was 339 beds.
Indication for PICC placement varied by location of device placement. For example, difficult IV access or blood draws was the commonest indication for PICC use in the ICU (35.1%), representing twice the rate of the same indication (16.6%) for PICCs placed on the ward (p < 0.001). Alternatively, over half of PICCs (53.3%) placed on the general ward were placed for IV antibiotic therapy compared with 19.8% of PICCs placed in the ICU for the same reason (p < 0.001) ( Table 1) . With respect to device characteristics, ICU PICCs were more often double or triple lumen compared with ward PICCs (59.5% vs 39.3%, 35.6% vs 2.8%, respectively; p < 0.001). Importantly, PICCs placed in the ICU also had a shorter median dwell time than ward PICCs (9 vs 16 d; p < 0.001) and were more often in place for less than or equal to 14 days when compared with PICCs placed on the general ward (67.1% vs 46.6%; p < 0.001) ( Table 2) .
Variation in Complications Between ICU and Ward PICCs
After adjustment, patients with PICCs placed in the ICU were associated with higher odds of experiencing the composite outcome (CLABSI, VTE, or catheter occlusion) compared with patients with a PICC placed on the wards (odds ratio [OR], 1.30; 95% CI, 1.18-1.43; p < 0.001). With respect to individual adverse events, patients with PICCs placed in the ICU were associated with a higher odds of developing catheter occlusion (OR, 1.91; 95% CI, 1.74-2.09; p < 0.001) and VTE (OR, 1.43; 95% CI, 1.22-1.68; p < 0.001). No significant differences in CLABSI were observed by location of PICC placement (OR, 0.99; 95% CI, 0.81-1.21; p = 0.906), although overall event rates were low ( Table 3) .
ICU PICC Use and Outcomes: Aggregate Analysis and Variation by Hospital (Site)
Amongst only ICU PICCs, vascular access nurses placed 6,268 PICCs (75.7%), whereas interventional radiology placed 933 PICCs (11.3%) ( Table 2 ). Composite complication rates and number of lumens did not differ by operator inserting the catheter. Patients with another CVC in place while in the ICU had higher rates of CLABSI (4.8% vs 1.9%; p < 0.001), VTE (7.1% vs 5.0%; p = 0.013), and catheter occlusion (18.1% vs 15.3%; p = 0.040) than those who did not. Compared with single-lumen devices, multilumen PICCs were associated with higher rates of the composite outcome (21.8% vs 8.3%; p < 0.001), including greater rates of CLABSI (2.3% vs 0.8%; p = 0.036), VTE (5.4% vs 1.8%; p < 0.001), and catheter occlusion (16.0% vs 6.5%; p < 0.001). Larger gauge PICCs (5 F or higher) were also associated with increased rates of the composite outcome (21.6% vs 13.5%; p < 0.001), including VTE (5.4% vs 3.1%; p = 0.042) and catheter occlusion (15.9% vs 10.6%; p = 0.004).
Indication for ICU PICC placement varied significantly across hospitals (p < 0.001). Although difficult access was the most common indication across the cohort (35.1%), the proportion of patients with this indication in ICUs ranged from 0% to 100%. The number of PICC lumens used in critically ill patients also varied across sites, with median single lumen use rates of 4.2% (interquartile range [IQR], 2.0-8.0%) but ranging from 0% to 100% (p < 0.001) (Fig. 1A) . Similar findings were observed for double and triple lumen PICC use across hospitals (p < 0.001). Median PICC dwell across sites significantly varied, with an overall median of 9.0 days (IQR, 8.0-10.3 d; range of 3-38.5 d; p < 0.001). Eighty-seven percent (n = 45) of hospitals reported a median PICC dwell time of less than or equal to 14 days (Fig. 1B) .
Complications experienced by patients with PICCs placed in the ICU significantly varied across sites (p < 0.001). The prevalence of the composite outcome (VTE, CLABSI, or catheter occlusion) ranged from 0% to 40.2% (p < 0.001), with a median 14.1% (IQR, 9.7-25.3%). Individual complications for ICU PICCs also varied widely (Fig. 2) . A total of 13 hospitals occupied the lowest 25th percentile for complication rates among all included hospitals, and more than half (n = 7) of these were low-volume sites. The 13 hospitals with the lowest complication rates also trended toward lesser inappropriate PICC use (64.2% vs 67.1%; p = 0.597) and fewer multilumen devices (83.5% vs 92.2%; p = 0.108).
DISCUSSION
In this study of 27,289 patients in 52 hospitals, we found significant differences in patterns of use and outcomes between PICCs placed in the ICU versus those placed in general wards. ICU PICCs were more often multilumen, larger gauge devices, potentially leading to higher rates of complications. However, no difference in CLABSI outcomes between ward and ICU PICCs were observed, likely due to low number of overall events. The majority of PICCs placed in the ICU (67.1%) had a dwell time of less than 14 days, a duration where traditional CVCs are considered more appropriate than PICCs. Importantly, substantial variation in PICC-associated outcomes was observed in the ICU, highlighting how these devices are not necessarily innocuous in critically ill patients. This is the first article to specifically characterize the epidemiology of PICC use and associated outcomes in the ICU across a large cohort of multiple hospitals and serves to inform future quality improvement work. Vascular access practices and outcomes have long been a focus of patient safety and quality improvement in the ICU (24) (25) (26) (27) . However, growing use of PICCs (1, 28) is changing practice in critically ill patients (9, 29) . Given the substantial morbidity and mortality associated with vascular access complications (6, 7), continuous evaluation and quality improvement efforts are needed. This is particularly important given that granular decisions regarding vascular access impact important patient outcomes (30, 31) , as demonstrated in this study. Intensive care practitioners must understand how these choices profoundly impact the care of their patients.
Recently, efforts to standardize better the use of PICCs in hospitalized patients have been made (18) . The Michigan Appropriateness Guide for IV Catheters (MAGIC) was developed using the Reaserach ANd Development/UCLA Appropriateness Methodology to help practitioners improve choice, care, and maintenance of PICCs in hospitalized patients. Using a modified Delphi approach, 15 panelists representing multiple disciplines (e.g., critical care, radiology, vascular nursing) reviewed data from systematic reviews of the literature to rate 665 clinical scenarios. For each scenario, panelists were asked to rate the risk and benefits of PICC use compared with other devices, regardless of cost. Given the risk of VTE associated with PICCs, MAGIC panelists rated PICC use in ICU settings as appropriate only when the expected duration of such use is 15 days or more (9, 32, 33) . CVCs are preferred over PICCs for durations of 6-14 days if central access is needed, given their overall lower risk of thrombosis. If peripheral access is necessary for 5 days or less, peripheral IV devices, including midline catheters, are appropriate.
Hospitals implementing MAGIC report improved outcomes (34). Our study extends this work and sheds light on the lack of standardized practice regarding PICC use in the ICU. For example, a specific recommendation from MAGIC is to avoid PICCs in the ICU when the anticipated duration is under 15 days. However, only 13% of hospitals (n = 7) had a median PICC duration in the ICU of 15 days or longer. Dissemination of guidelines into clinical practice is challenging and requires specific implementation strategies (35, 36) . Although it can be difficult to project the expected duration of vascular access, contextual, and provider-specific factors such as patient safety culture (37) and provider awareness of guidelines (38) may also influence device use. Further work is needed to understand the barriers and facilitators in effectively deploying tools such as MAGIC in ICUs on a local, regional, and national level.
There are limitations to our study. First, the HMS consortium is focused on medical patients given the stipulations within our quality collaborative; lack of surgical patients limits generalizability of findings. Second, our data focuses on PICC use and outcomes and suffers from lack of a suitable comparator, namely CVCs. However, mounting evidence suggests PICCs are associated with similar or greater risk of adverse events to CVCs in the ICU setting (39) . Although future work evaluating both devices is necessary, our data serves to highlight the risks of PICC use in this setting. Such an understanding of device-specific utilization patterns is essential to effectively develop future decision support tools. Finally, data used in this study were collected through review of medical records. Although this allowed for a granular assessment of multiple variables, these data are susceptible to reporting bias. However, because we used trained abstractors and a systematic approach to collect data, we believe this risk was minimized.
There are several strengths to this study. First, the nature of the study with a large sample size of 29,289 patients provides a robust, real-world view of PICC use and outcomes. Second, the multicenter aspect of the study with 52 hospitals means that these results are generalizable to medical patients in healthcare settings from a variety of contexts. Third, the fact that the database is composed from primary data collection by trained abstractors allows for a detailed assessment of key clinical variables that are often absent in secondary databases.
CONCLUSIONS
Vascular access decisions are some of the most important aspects to caring for critically ill patients. Although much work has already been done to improve outcomes in the ICU (40) (41) (42) , increasing use of PICCs has changed the landscape. Our study demonstrates that more lumens and larger gauge catheters are associated with higher complication rates in the ICU. Importantly, we also show substantial variation in ICU PICC use across hospitals, which highlights important ways in which practice can be improved. Additional efforts are needed to better understand how critical care practitioners make decisions regarding vascular access in the ICU. In doing so, the medical community will be better equipped to design and implement targeted interventions toward improving vascular outcomes in critically ill patients on a regional and national scale.
